The HMS China Clinical Trials program provides clinicians and clinician-scientists advanced training in the methods and conduct of clinical research. In addition to covering basic concepts in epidemiology, biostatistics, study design and research ethics, the course will tap into a global network of like-minded colleagues to foster an exchange of information and the opportunity to collaborate.

Learning Objectives

The program will take a deep dive into the workshop curriculum through various modes of learning. Through lectures on hospital operations and site visits, participants will get a behind-the-scenes look at how safer, higher quality health care is delivered in Harvard Medical School-affiliated hospitals.

Participants will also gain access to the latest innovation and expertise from hospital leaders through Harvard Business School case studies and panel discussions. Course faculty will address the curriculum using a selected quality or safety challenge to help translate knowledge into practice.

The objectives of this workshop are:

  • To understand the drug discovery and developmental pathway – the pitfalls and opportunities
  • To understand the importance of leadership and teamwork in drug development
  • To recognize how evidence from observational research and clinical trials inform strategy and implementation


  • Workshop Faculty

    Ebrahim Barkoudah, MD, MPH, FACP, FHM
    Instructor in Medicine
    Harvard Medical School

    Kenneth B. Christopher, MD, SM
    Assistant Professor of Medicine
    Harvard Medical School

    Vanessa Garcia-Larsen, PhD, MSc
    Assistant Professor
    Johns Hopkins Bloomberg School of Public Health

    Susan Z. Kornetsky, MPH
    Director of Clinical Research Compliance
    Boston Children's Hospital

    Melvyn Menezes, PhD, MBA
    Associate Professor of Marketing
    Boston University

    Paula Sandler, PhD
    Vice President, Regulatory Affairs

    Aneesh Singhal, MD
    Associate Professor of Neurology
    Harvard Medical School